波音游戏-波音娱乐城赌球打不开

CityUHK’s IDM establishes partnership with Korea’s Samsung Advanced Institute for Health Sciences & Technology

 

M Yang
The MoU is signed by Professor Yang (left) and Professor Chang in Seoul, Korea.

The Institute of Digital Medicine (IDM) of City University of Hong Kong (CityUHK) and the Samsung Advanced Institute for Health Sciences & Technology (SAIHST) in Korea signed a Memorandum of Understanding (MoU) in Seoul on 18 March. It aims to establish collaboration on health-related research, particularly in cell and gene therapy, bioinformatics and biomedical engineering, as well as talent development and commercialising digital health solutions to benefit society.

The MoU was signed by Professor Michael Yang Mengsu, Senior Vice-President (Innovation and Enterprise) at CityUHK, and Professor Chang Yun Sil, Director of SAIHST.

SAIHST is a leading institute, jointly established by industry – Samsung Group, a hospital – Samsung Medical Center, and academia – Sungkyunkwan University (SKKU) – to advance research and nurture professional experts to lead the future of biomedical sciences. SAIHST is Korea’s first graduate school of interdisciplinary convergence medical science to conduct healthcare-focused research and education. The institute partnered with universities and research institutes in more than 10 countries, such as the United States, Canada, the United Kingdom, France, and partnership with domestic and global pharmaceutical companies, large corporations and biotech firms.

IDM was established in April 2024. In collaboration with renowned universities and medical schools around the world, as well as clinical and industry partners and health tech investors, IDM utilises CityUHK’s research strengths in engineering, data science and life science to develop innovative technologies to explore digital health solutions, for the long-term benefit of doctors and patients.

 “Global collaboration is crucial for the development of digital medicine,” said Professor Freddy Boey, President of CityUHK. “The partnership between IDM and SAIHST marks a significant milestone in advancing health technology innovation. With CityUHK’s dynamic innovation and entrepreneurial ecosystem, I am confident that our joint efforts will empower our future leaders on the global stage and create a positive impact on Hong Kong, Korea, and beyond.”

photo1
CityUHK's IDM and the SAIHST in Korea have established collaboration to advance health-related research, and promote talent development and commercialising digital health solutions, benefiting society in the long term.

IDM and SAIHST will establish talent-nurturing collaboration with an international perspective. SAIHST will support eligible top-tier researchers and scientists by facilitating their visits to Hong Kong, participating in programmes offered by the CityUHK Academy of Innovation, and providing internship opportunities for CityUHK students.

The two parties will strengthen their partnership in health-related innovations through CityUHK’s HK Tech 300 programme, jointly transforming innovative ideas into practical applications and promoting the development of deep-tech start-ups.

Following the signing ceremony, CityUHK's IDM delegation held discussions with professors from four SAIHST departments: Health Sciences and Technology, Digital Health, Medical Device Management and Research, and Clinical Research Design and Evaluation, and shared the development of CityUHK's IDM.

YOU MAY BE INTERESTED

Contact Information

Communications and Institutional Research Office

Back to top
六合彩现场| 大发888真钱游戏下载| 大发888官网z46| 足球博彩| 百家乐专业豪华版| 百家乐官网噢门棋牌| 百家乐官网决战推筒子| 百家乐是娱乐场| 多伦多百家乐官网的玩法技巧和规则| 大发888游戏平台hg dafa888 gw| 沙龙百家乐娱乐场开户注册| 杨公24山择日| 百家乐官网英皇娱乐场开户注册| 蒙特卡罗国际网址| 百家乐和21点| 24岁掉牙齿 风水| 定襄县| 德州扑克怎么玩的| bet365国际娱乐| 五张百家乐的玩法技巧和规则| 百家乐娱乐城信息| 澳门百家乐官网真人版| 香港百家乐官网赌场| 百家乐官网赢赌场百家乐官网| 威尼斯人娱乐场棋牌| 百家乐经验在哪找| 百家乐官网变牌桌| 百家乐官网平台哪个好本站所有数据都是网友推荐及提供 | 张家界市| 威尼斯人娱乐平台最新地址| 百家乐官网开户过的路纸| 百家乐官网入庄闲概率| 百家乐官网翻天qvod| 百家乐官网说明| 百家乐官网庄闲桌| 捷豹百家乐官网娱乐城| 百家乐官网筹码方形| 大名县| 百家乐官网平注常赢打法| 澳门百家乐官网牌例| 网络百家乐官网破解器|